Literature DB >> 10588861

In Xenopus embryos, BMP heterodimers are not required for mesoderm induction, but BMP activity is necessary for dorsal/ventral patterning.

P M Eimon1, R M Harland.   

Abstract

The activity of bone morphogenetic protein (BMP) heterodimers has been shown to be more potent than that of homodimers in a number of contexts, including mesoderm induction. Although BMP-2/7 and -4/7 heterodimers are potent inducers of ventral mesoderm in ectodermal explants, we show that they are not a necessary component of the primary mesoderm-inducing signal in intact Xenopus embryos. The secreted BMP antagonists noggin and gremlin both efficiently block mesoderm induction by BMP homo- and heterodimers in animal caps. When these antagonists are ectopically expressed in the ventral marginal zone of early embryos the initial formation of mesoderm as indicated by panmesodermal markers remains unaffected. Only the subsequent dorsal/ventral patterning of this mesoderm appears to be altered, with expression of a number of organizer-specific transcripts observed in the marginal zone where BMP signaling has been abolished. Thus, we conclude that BMPs do not contribute an essential signal to mesodermal induction or patterning until gastrulation. The activities of noggin and gremlin are strikingly different from that of the multifunctional antagonist cerberus, which completely abolishes mesoderm induction when misexpressed during early development. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10588861     DOI: 10.1006/dbio.1999.9496

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  12 in total

1.  Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells.

Authors:  W Wang; F V Mariani; R M Harland; K Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif.

Authors:  S Germain; M Howell; G M Esslemont; C S Hill
Journal:  Genes Dev       Date:  2000-02-15       Impact factor: 11.361

Review 3.  Regulation of bone morphogenetic proteins in early embryonic development.

Authors:  Yukiyo Yamamoto; Michael Oelgeschläger
Journal:  Naturwissenschaften       Date:  2004-10-26

4.  The role of FGF signaling in the establishment and maintenance of mesodermal gene expression in Xenopus.

Authors:  Russell B Fletcher; Richard M Harland
Journal:  Dev Dyn       Date:  2008-05       Impact factor: 3.780

Review 5.  TGF-β Family Signaling in Early Vertebrate Development.

Authors:  Joseph Zinski; Benjamin Tajer; Mary C Mullins
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

6.  A maternal Smad protein regulates early embryonic apoptosis in Xenopus laevis.

Authors:  Yuko Miyanaga; Ingrid Torregroza; Todd Evans
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

7.  Dynamics of BMP signaling in limb bud mesenchyme and polydactyly.

Authors:  Jacqueline L Norrie; Jordan P Lewandowski; Cortney M Bouldin; Smita Amarnath; Qiang Li; Martha S Vokes; Lauren I R Ehrlich; Brian D Harfe; Steven A Vokes
Journal:  Dev Biol       Date:  2014-07-14       Impact factor: 3.582

8.  BMP and BMP receptor expression during murine organogenesis.

Authors:  Shahab M Danesh; Alethia Villasenor; Diana Chong; Carrie Soukup; Ondine Cleaver
Journal:  Gene Expr Patterns       Date:  2009-04-22       Impact factor: 1.224

Review 9.  TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology.

Authors:  Masato Morikawa; Rik Derynck; Kohei Miyazono
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-05-02       Impact factor: 10.005

10.  Chordin expression, mediated by Nodal and FGF signaling, is restricted by redundant function of two beta-catenins in the zebrafish embryo.

Authors:  Máté Varga; Shingo Maegawa; Gianfranco Bellipanni; Eric S Weinberg
Journal:  Mech Dev       Date:  2007-06-12       Impact factor: 1.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.